Redmile Group, LLC

Insider Reports History

Entity: Company
Location: One Letterman Drive, Building D, Suite D3 300, San Francisco, CA
Signature: By: /s/ Jeremy Green, Managing Member of Redmile Group, LLC
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Redmile Group, LLC:

Stock	Role	Class	Num Shares	Value	Price $	Report Date	Ownership
RayzeBio, Inc.	10%+ Owner	Common Stock	1.86M	$116M	$62.50	Sep 19, 2023	Indirect
ADC Therapeutics SA	10%+ Owner	Common Shares, par value CHF 0.08 per share	15.7M	$59.7M	$3.81	Dec 11, 2024	Indirect
ADC Therapeutics SA	10%+ Owner	Common Shares, par value CHF 0.08 per share	13.1M	$50.1M	$3.81	Dec 11, 2024	Direct
IGM Biosciences, Inc.	Director, 10%+ Owner	Non-Voting Common Stock	7.2M	$47.5M	$6.60	Feb 28, 2024	Indirect
ADC Therapeutics SA	10%+ Owner	Common Shares, par value CHF 0.08 per share	15.7M	$44M	$2.81	Jul 1, 2024	Indirect
Absci Corp	Director	Common Stock	8.26M	$41.1M	$4.98	Jun 12, 2024	Indirect
ADC Therapeutics SA	10%+ Owner	Common Shares, par value CHF 0.08 per share	13M	$36.5M	$2.81	Jul 1, 2024	Direct
Entrada Therapeutics, Inc.	10%+ Owner	Common Stock	1.95M	$31.3M	$15.99	Nov 2, 2021	Indirect
Zymeworks Inc.	10%+ Owner	Common Stock, par value $0.00001 per share	6.08M	$30.6M	$5.03	Oct 13, 2022	Indirect
FATE THERAPEUTICS INC	Director, 10%+ Owner	Class A Convertible Preferred Stock	2.76M	$23.1M	$8.40	Dec 20, 2024	Indirect
IGM Biosciences, Inc.	Director, 10%+ Owner	Common Stock	2.96M	$22.2M	$7.48	Dec 31, 2024	Indirect
FATE THERAPEUTICS INC	Director, 10%+ Owner	Common Stock	12.9M	$21.6M	$1.68	Dec 20, 2024	Indirect
FATE THERAPEUTICS INC	Director, 10%+ Owner	Pre-Funded Warrants to Purchase Common Stock	3.89M	$21.4M	$5.50	Mar 21, 2024	Indirect
Verve Therapeutics, Inc.	10%+ Owner	Common Stock	1.94M	$19.4M	$10.00	Jun 21, 2021	Indirect
ADC Therapeutics SA	10%+ Owner	Pre-Funded Warrants	8.16M	$16.9M	$2.07	Dec 4, 2024	Indirect
Adagio Therapeutics, Inc.	10%+ Owner	Common Stock	3.39M	$13.4M	$3.95	Aug 10, 2021	Indirect
ADC Therapeutics SA	10%+ Owner	Pre-Funded Warrants	6.13M	$12.7M	$2.07	Dec 4, 2024	Direct
Shattuck Labs, Inc.	Director, 10%+ Owner	Common Stock, par value $0.0001 per share	5.54M	$6.92M	$1.25	Dec 4, 2024	Indirect
FATE THERAPEUTICS INC	Director, 10%+ Owner	Cash-settled Swaps	503K	$845K	$1.68	Dec 20, 2024	Indirect
ADC Therapeutics SA	10%+ Owner	Cash-settled Swaps	108K	$364K	$3.38	Feb 7, 2024	Direct
FATE THERAPEUTICS INC	Director, 10%+ Owner	Stock Option (Right to Buy)	40K	$109K	$2.73	Jun 7, 2024	Indirect
ADC Therapeutics SA	10%+ Owner	Cash-settled Swaps	11.2K	$37.8K	$3.38	Feb 2, 2024	Indirect
Augmedix, Inc.	Director, 10%+ Owner	Common Stock	0	$0	$2.35	Oct 2, 2024	Direct
Augmedix, Inc.	Director, 10%+ Owner	Common Stock	0	$0	$2.35	Oct 2, 2024	Indirect
Science 37 Holdings, Inc.	Former 10% Owner and Director	Common Stock	0	$0	$5.75	Mar 12, 2024	Indirect
MedAvail Holdings, Inc.	Director, 10%+ Owner	Series A Warrants to Purchase Common Stock	38.9M			Jun 16, 2023	Direct
MedAvail Holdings, Inc.	Director, 10%+ Owner	Series A Warrants to Purchase Common Stock	38.9M			Jun 16, 2023	Indirect
Shattuck Labs, Inc.	Director, 10%+ Owner	Pre-Funded Warrant to Purchase Common Stock	3.1M			Dec 21, 2023	Indirect
Augmedix, Inc.	Director, 10%+ Owner	Breakeven Warrant	1.09M			Nov 20, 2023	Direct
Augmedix, Inc.	Director, 10%+ Owner	Breakeven Warrant	1.09M			Nov 20, 2023	Indirect
Absci Corp	Director	Stock Option (Right to Buy)	36.3K			Jun 12, 2024	Indirect
IGM Biosciences, Inc.	Director, 10%+ Owner	Stock Option (Right to Buy)	29.4K			Mar 12, 2024	Indirect
Shattuck Labs, Inc.	Director, 10%+ Owner	Stock Option (Right to Buy)	27.7K			Jun 21, 2024	Indirect
Adagio Therapeutics, Inc.	10%+ Owner	Series C Preferred Stock	0			Aug 10, 2021	Indirect
Augmedix, Inc.	Director, 10%+ Owner	Breakeven Warrants	0			Oct 2, 2024	Direct
Augmedix, Inc.	Director, 10%+ Owner	Breakeven Warrants	0			Oct 2, 2024	Indirect
Augmedix, Inc.	Director, 10%+ Owner	Pre-Funded Warrants to Purchase Common Stock	0			Oct 2, 2024	Direct
Augmedix, Inc.	Director, 10%+ Owner	Pre-Funded Warrants to Purchase Common Stock	0			Oct 2, 2024	Indirect
Entrada Therapeutics, Inc.	10%+ Owner	Series B Convertible Preferred Stock	0			Nov 2, 2021	Indirect
RayzeBio, Inc.	10%+ Owner	Series B Preferred Stock	0			Sep 19, 2023	Indirect
RayzeBio, Inc.	10%+ Owner	Series C Preferred Stock	0			Sep 19, 2023	Indirect
RayzeBio, Inc.	10%+ Owner	Series D Preferred Stock	0			Sep 19, 2023	Indirect
Science 37 Holdings, Inc.	Former 10% Owner and Director	Earn-Out Right	0			Mar 12, 2024	Indirect
Science 37 Holdings, Inc.	Former 10% Owner and Director	Stock Options (Right to Buy)	0			Mar 12, 2024	Indirect
Verve Therapeutics, Inc.	10%+ Owner	Series B Convertible Preferred Stock	0			Jun 21, 2021	Indirect

Previous1Next

Showing 1 to 45 of 45 entries

Insider Reports Filed by Redmile Group, LLC

Symbol	Company	Period	Transactions	Value $	Form Type	Date Filed	Role
IGMS	IGM Biosciences, Inc.	Dec 31, 2024	1	$0	4	Jan 2, 2025	Director, 10%+ Owner
FATE	FATE THERAPEUTICS INC	Dec 20, 2024	7	$0	4	Dec 26, 2024	Director, 10%+ Owner
FATE	FATE THERAPEUTICS INC	Dec 12, 2024	2	$0	4	Dec 16, 2024	Director, 10%+ Owner
ADCT	ADC Therapeutics SA	Dec 11, 2024	4	$609K	4	Dec 13, 2024	10%+ Owner
ADCT	ADC Therapeutics SA	Dec 4, 2024	7	$108K	4	Dec 6, 2024	10%+ Owner
STTK	Shattuck Labs, Inc.	Dec 4, 2024	4	$0	4	Dec 6, 2024	Director, 10%+ Owner
AUGX	Augmedix, Inc.	Oct 2, 2024	7	-$75.4M	4	Oct 4, 2024	Director, 10%+ Owner
IGMS	IGM Biosciences, Inc.	Sep 30, 2024	1	$0	4	Oct 2, 2024	Director, 10%+ Owner
ADCT	ADC Therapeutics SA	Jul 1, 2024	2	$2.25M	4	Jul 3, 2024	10%+ Owner
IGMS	IGM Biosciences, Inc.	Jun 28, 2024	1	$0	4	Jul 2, 2024	Director, 10%+ Owner
STTK	Shattuck Labs, Inc.	Jun 21, 2024	1	$0	4	Jun 21, 2024	Director, 10%+ Owner
AUGX	Augmedix, Inc.	Jun 14, 2024	1	$0	4	Jun 18, 2024	Director, 10%+ Owner
ABSI	Absci Corp	Jun 12, 2024	2	$0	4	Jun 14, 2024	Director
FATE	FATE THERAPEUTICS INC	Jun 7, 2024	1	$0	4	Jun 11, 2024	Director, 10%+ Owner
ADCT	ADC Therapeutics SA	May 8, 2024	2	$68.7M	4	May 10, 2024	10%+ Owner
STTK	Shattuck Labs, Inc.	Mar 28, 2024	1	$0	4	Apr 1, 2024	Director, 10%+ Owner
IGMS	IGM Biosciences, Inc.	Mar 28, 2024	2	$0	4	Apr 1, 2024	Director, 10%+ Owner
FATE	FATE THERAPEUTICS INC	Mar 21, 2024	1	$20M	4	Mar 25, 2024	Director, 10%+ Owner
AUGX	Augmedix, Inc.	Mar 15, 2024	1	$0	4	Mar 19, 2024	Director, 10%+ Owner
IGMS	IGM Biosciences, Inc.	Mar 12, 2024	1	$0	4	Mar 14, 2024	Director, 10%+ Owner
SNCE	Science 37 Holdings, Inc.	Mar 12, 2024	3	-$5.85M	4	Mar 13, 2024	Former 10% Owner and Director
ABSI	Absci Corp	Mar 1, 2024	1	$1M	4	Mar 5, 2024	Director
IGMS	IGM Biosciences, Inc.	Feb 28, 2024	2	$0	4	Mar 1, 2024	Director, 10%+ Owner
ADCT	ADC Therapeutics SA	Jan 3, 2024	22	-$167K	4	Feb 9, 2024	10%+ Owner
ADCT	ADC Therapeutics SA	Jan 2, 2024	0	$0	3	Feb 9, 2024	10%+ Owner
IGMS	IGM Biosciences, Inc.	Dec 29, 2023	1	$0	4	Jan 3, 2024	Director
FATE	FATE THERAPEUTICS INC	Dec 26, 2023	3	$166K	4	Dec 28, 2023	Director, 10%+ Owner
STTK	Shattuck Labs, Inc.	Dec 21, 2023	1	$0	4	Dec 26, 2023	Director, 10%+ Owner
AUGX	Augmedix, Inc.	Dec 15, 2023	1	$0	4	Dec 19, 2023	Director, 10%+ Owner
AUGX	Augmedix, Inc.	Nov 20, 2023	4	$6M	4	Nov 22, 2023	Director, 10%+ Owner
IGMS	IGM Biosciences, Inc.	Sep 29, 2023	1	$0	4	Oct 3, 2023	Director
RYZB	RayzeBio, Inc.	Sep 19, 2023	6	$0	4	Sep 21, 2023	10%+ Owner
RYZB	RayzeBio, Inc.	Sep 14, 2023	0	$0	3	Sep 14, 2023	10%+ Owner
AUGX	Augmedix, Inc.	Aug 31, 2023	1	$10K	4	Sep 5, 2023	Director, 10%+ Owner
AUGX	Augmedix, Inc.	Jul 13, 2023	1	$0	4	Jul 17, 2023	Director, 10%+ Owner
IGMS	IGM Biosciences, Inc.	Jun 29, 2023	5	$0	4	Jul 3, 2023	Director
IGMS	IGM Biosciences, Inc.	Jun 26, 2023	1	$22.5M	4	Jun 28, 2023	Director
MDVL	MedAvail Holdings, Inc.	Jun 16, 2023	2	$0	4	Jun 21, 2023	Director, 10%+ Owner
ABSI	Absci Corp	Jun 14, 2023	1	$0	4	Jun 16, 2023	Director
FATE	FATE THERAPEUTICS INC	Jun 6, 2023	1	$0	4	Jun 8, 2023	Director, 10%+ Owner
STTK	Shattuck Labs, Inc.	May 26, 2023	1	$0	4	May 31, 2023	Director, 10%+ Owner
SNCE	Science 37 Holdings, Inc.	May 11, 2023	1	$125K	4	May 15, 2023	Director, 10%+ Owner
AUGX	Augmedix, Inc.	May 2, 2023	3	-$15M	4	May 4, 2023	Director, 10%+ Owner
FATE	FATE THERAPEUTICS INC	Apr 20, 2023	2	$1.71M	4	Apr 21, 2023	Director, 10%+ Owner
AUGX	Augmedix, Inc.	Apr 19, 2023	2	$7M	4	Apr 21, 2023	Director, 10%+ Owner
FATE	FATE THERAPEUTICS INC	Apr 13, 2023	12	-$1.61M	4	Apr 17, 2023	Director, 10%+ Owner
IGMS	IGM Biosciences, Inc.	Apr 4, 2023	1	$0	4	Apr 6, 2023	Director, 10%+ Owner
IGMS	IGM Biosciences, Inc.	Mar 31, 2023	1	$0	4	Apr 4, 2023	Director, 10%+ Owner
MDVL	MedAvail Holdings, Inc.	Mar 9, 2023	2	$25M	4	Mar 13, 2023	Director, 10%+ Owner
IGMS	IGM Biosciences, Inc.	Dec 30, 2022	1	$0	4	Jan 4, 2023	Director, 10%+ Owner
ZYME	Zymeworks Inc.	Oct 13, 2022	1	$153K	4/A	Oct 18, 2022	10%+ Owner
ZYME	Zymeworks Inc.	Oct 13, 2022	0	$0	3	Oct 17, 2022	10%+ Owner
ZYME	Zymeworks Inc.	Oct 13, 2022	0	$0	3	Oct 17, 2022	10%+ Owner
IGMS	IGM Biosciences, Inc.	Oct 3, 2022	6	$0	4	Oct 5, 2022	Director, 10%+ Owner
IGMS	IGM Biosciences, Inc.	Sep 30, 2022	1	$0	4	Oct 4, 2022	Director, 10%+ Owner
MDVL	MedAvail Holdings, Inc.	Jul 1, 2022	4	$18.1M	4	Jul 6, 2022	Director, 10%+ Owner
IGMS	IGM Biosciences, Inc.	Jun 30, 2022	1	$0	4	Jul 5, 2022	Director, 10%+ Owner
SNCE	Science 37 Holdings, Inc.	Jun 13, 2022	2	$0	4	Jun 15, 2022	Director, 10%+ Owner
FATE	FATE THERAPEUTICS INC	Jun 9, 2022	2	$0	4	Jun 13, 2022	Director, 10%+ Owner
STTK	Shattuck Labs, Inc.	Jun 8, 2022	1	$0	4	Jun 10, 2022	Director, 10%+ Owner
ABSI	Absci Corp	Jun 8, 2022	1	$0	4	Jun 10, 2022	Director, 10%+ Owner
SNCE	Science 37 Holdings, Inc.	May 23, 2022	1	$125K	4	May 25, 2022	Director, 10%+ Owner
MDVL	MedAvail Holdings, Inc.	Apr 4, 2022	2	$15M	4	Apr 6, 2022	Director, 10%+ Owner
IGMS	IGM Biosciences, Inc.	Mar 31, 2022	2	$60M	4	Apr 4, 2022	Director, 10%+ Owner
IGMS	IGM Biosciences, Inc.	Mar 12, 2022	1	$0	4	Mar 15, 2022	Director, 10%+ Owner
IGMS	IGM Biosciences, Inc.	Dec 31, 2021	1	$0	4	Jan 4, 2022	Director, 10%+ Owner
TRDA	Entrada Therapeutics, Inc.	Nov 2, 2021	3	$20M	4	Nov 4, 2021	10%+ Owner
AUGX	Augmedix, Inc.	Oct 28, 2021	1	$6.5M	4/A	Apr 21, 2023	Director, 10%+ Owner
TRDA	Entrada Therapeutics, Inc.	Oct 28, 2021	0	$0	3	Oct 28, 2021	10%+ Owner
SNCE	Science 37 Holdings, Inc.	Oct 7, 2021	1	$0	4	Oct 12, 2021	Director, 10%+ Owner
SNCE	Science 37 Holdings, Inc.	Oct 6, 2021	1	$0	4/A	Oct 18, 2021	Director, 10%+ Owner
SNCE	Science 37 Holdings, Inc.	Oct 6, 2021	0	$0	3	Oct 8, 2021	Director, 10%+ Owner
IGMS	IGM Biosciences, Inc.	Sep 30, 2021	1	$0	4	Oct 4, 2021	Director, 10%+ Owner
IVVD	Adagio Therapeutics, Inc.	Aug 10, 2021	3	$25M	4	Aug 12, 2021	10%+ Owner
IVVD	Adagio Therapeutics, Inc.	Aug 5, 2021	0	$0	3	Aug 5, 2021	10%+ Owner
ABSI	Absci Corp	Jul 26, 2021	5	$5M	4	Jul 28, 2021	Director
ABSI	Absci Corp	Jul 21, 2021	0	$0	3	Jul 21, 2021	Director, 10%+ Owner
IGMS	IGM Biosciences, Inc.	Jun 30, 2021	1	$0	4	Jul 2, 2021	Director, 10%+ Owner
VERV	Verve Therapeutics, Inc.	Jun 21, 2021	3	$20M	4	Jun 23, 2021	10%+ Owner
STTK	Shattuck Labs, Inc.	Jun 19, 2021	1	$0	4	Jun 22, 2021	Director, 10%+ Owner
VERV	Verve Therapeutics, Inc.	Jun 16, 2021	0	$0	3	Jun 16, 2021	10%+ Owner
FATE	FATE THERAPEUTICS INC	Jun 2, 2021	2	$0	4	Jun 4, 2021	Director, 10%+ Owner